{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:55:33Z","timestamp":1788573333605,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multilineage-differentiating stress-enduring (Muse) cells are endogenous reparative pluripotent stem cells present in the bone marrow, peripheral blood, and organ connective tissues. We assessed the homing and therapeutic effects of systemically administered nafimestrocel, a clinical-grade human Muse cell-based product, without immunosuppressants in a neonatal hypoxic\u2013ischemic (HI) rat model. HI injury was induced on postnatal day 7 (P7) and was confirmed by T2-weighted magnetic resonance imaging on P10. HI rats received a single dose nafimestrocel (1\u2009\u00d7\u200910<jats:sup>6<\/jats:sup> cells\/body) or Hank\u2019s balanced salt solution (vehicle group) intravenously at either three days (on P10; M3 group) or seven days (on P14; M7 group) after HI insult. Radioisotope experiment demonstrated the homing of chromium-51-labeled nafimestrocel to the both cerebral hemispheres. The cylinder test (M3 and M7 groups) and open-field test (M7 group) showed significant amelioration of paralysis and hyperactivity at five weeks of age compared with those in the vehicle group. Nafimestrocel did not cause adverse events such as death or pathological changes in the lung at ten weeks in the both groups. Nafimestrocel attenuated the production of tumor necrosis factor-\u03b1 and inducible nitric oxide synthase from activated cultured microglia in vitro. These results demonstrate the potential therapeutic benefits and safety of nafimestrocel.<\/jats:p>","DOI":"10.1038\/s41598-023-41026-3","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T10:02:24Z","timestamp":1694426544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Systemic administration of clinical-grade multilineage-differentiating stress-enduring cells ameliorates hypoxic\u2013ischemic brain injury in neonatal rats"],"prefix":"10.1038","volume":"13","author":[{"given":"Kazuto","family":"Ueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuto","family":"Onoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Mimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Kitase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Dezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"41026_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/ped.12233","volume":"56","author":"M Hayakawa","year":"2014","unstructured":"Hayakawa, M. et al. Incidence and prediction of outcome in hypoxic-ischemic encephalopathy in Japan. Pediatr. Int. 56, 215\u2013221. https:\/\/doi.org\/10.1111\/ped.12233 (2014).","journal-title":"Pediatr. Int."},{"key":"41026_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","volume":"86","author":"JJ Kurinczuk","year":"2010","unstructured":"Kurinczuk, J. J., White-Koning, M. & Badawi, N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Human Dev. 86, 329\u2013338. https:\/\/doi.org\/10.1016\/j.earlhumdev.2010.05.010 (2010).","journal-title":"Early Human Dev."},{"key":"41026_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/ana.23647","volume":"72","author":"JJ Volpe","year":"2012","unstructured":"Volpe, J. J. Neonatal encephalopathy: An inadequate term for hypoxic-ischemic encephalopathy. Ann. Neurol. 72, 156\u2013166. https:\/\/doi.org\/10.1002\/ana.23647 (2012).","journal-title":"Ann. Neurol."},{"key":"41026_CR4","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1056\/NEJMcps050929","volume":"353","author":"S Shankaran","year":"2005","unstructured":"Shankaran, S. et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N. Engl. J. Med. 353, 1574\u20131584. https:\/\/doi.org\/10.1056\/NEJMcps050929 (2005).","journal-title":"N. Engl. J. Med."},{"key":"41026_CR5","doi-asserted-by":"publisher","unstructured":"Edwards, A. D. et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: Synthesis and meta-analysis of trial data. BMJ (Clin. Res. ed.) 340, c363. https:\/\/doi.org\/10.1136\/bmj.c363 (2010).","DOI":"10.1136\/bmj.c363"},{"key":"41026_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/0271678x18811277","volume":"39","author":"CV Borlongan","year":"2019","unstructured":"Borlongan, C. V. et al. May the force be with you: Transfer of healthy mitochondria from stem cells to stroke cells. J. Cereb. Blood Flow Metab. 39, 367\u2013370. https:\/\/doi.org\/10.1177\/0271678x18811277 (2019).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"41026_CR7","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1016\/j.pmrj.2018.07.008","volume":"10","author":"TK Watanabe","year":"2018","unstructured":"Watanabe, T. K. A review of stem cell therapy for acquired brain injuries and neurodegenerative central nervous system diseases. PM R 10, S151\u2013S156. https:\/\/doi.org\/10.1016\/j.pmrj.2018.07.008 (2018).","journal-title":"PM R"},{"key":"41026_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.brainres.2015.06.053","volume":"1638","author":"M Levy","year":"2016","unstructured":"Levy, M., Boulis, N., Rao, M. & Svendsen, C. N. Regenerative cellular therapies for neurologic diseases. Brain Res. 1638, 88\u201396. https:\/\/doi.org\/10.1016\/j.brainres.2015.06.053 (2016).","journal-title":"Brain Res."},{"key":"41026_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1933719108317299","volume":"15","author":"Y Sato","year":"2008","unstructured":"Sato, Y. et al. Reduction of brain injury in neonatal hypoxic-ischemic rats by intracerebroventricular injection of neural stem\/progenitor cells together with chondroitinase ABC. Reprod. Sci. 15, 613\u2013620. https:\/\/doi.org\/10.1177\/1933719108317299 (2008).","journal-title":"Reprod. Sci."},{"key":"41026_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/157488809789057419","volume":"4","author":"Y Sato","year":"2009","unstructured":"Sato, Y. & Oohira, A. Chondroitin sulfate, a major niche substance of neural stem cells, and cell transplantation therapy of neurodegeneration combined with niche modification. Curr. Stem Cell Res. Ther. 4, 200\u2013209. https:\/\/doi.org\/10.2174\/157488809789057419 (2009).","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"41026_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000368396","volume":"37","author":"T Hattori","year":"2015","unstructured":"Hattori, T. et al. Administration of umbilical cord blood cells transiently decreased hypoxic-ischemic brain injury in neonatal rats. Dev. Neurosci. 37, 95\u2013104. https:\/\/doi.org\/10.1159\/000368396 (2015).","journal-title":"Dev. Neurosci."},{"key":"41026_CR12","doi-asserted-by":"publisher","first-page":"44111","DOI":"10.1038\/srep44111","volume":"7","author":"K Nakanishi","year":"2017","unstructured":"Nakanishi, K. et al. Rat umbilical cord blood cells attenuate hypoxic-ischemic brain injury in neonatal rats. Sci. Rep. 7, 44111. https:\/\/doi.org\/10.1038\/srep44111 (2017).","journal-title":"Sci. Rep."},{"key":"41026_CR13","doi-asserted-by":"publisher","unstructured":"Sugiyama, Y. et al. Intravenous administration of bone marrow-derived mesenchymal stem cell, but not adipose tissue-derived stem cell, ameliorated the neonatal hypoxic-ischemic brain injury by changing cerebral inflammatory state in rat. Front. Neurol. https:\/\/doi.org\/10.3389\/fneur.2018.00757 (2018).","DOI":"10.3389\/fneur.2018.00757"},{"key":"41026_CR14","doi-asserted-by":"publisher","first-page":"8639","DOI":"10.1073\/pnas.0911647107","volume":"107","author":"Y Kuroda","year":"2010","unstructured":"Kuroda, Y. et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc. Natl. Acad. Sci. USA 107, 8639\u20138643. https:\/\/doi.org\/10.1073\/pnas.0911647107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"41026_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-4-431-56847-6_3","volume":"1103","author":"Y Kushida","year":"2018","unstructured":"Kushida, Y., Wakao, S. & Dezawa, M. Muse cells are endogenous reparative stem cells. Adv. Exp. Med. Biol. 1103, 43\u201368. https:\/\/doi.org\/10.1007\/978-4-431-56847-6_3 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"41026_CR16","doi-asserted-by":"publisher","first-page":"9875","DOI":"10.1073\/pnas.1100816108","volume":"108","author":"S Wakao","year":"2011","unstructured":"Wakao, S. et al. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc. Natl. Acad. Sci. USA 108, 9875\u20139880. https:\/\/doi.org\/10.1073\/pnas.1100816108 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"41026_CR17","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/cells1041045","volume":"1","author":"S Wakao","year":"2012","unstructured":"Wakao, S., Kuroda, Y., Ogura, F., Shigemoto, T. & Dezawa, M. Regenerative effects of mesenchymal stem cells: contribution of muse cells, a novel pluripotent stem cell type that resides in mesenchymal cells. Cells 1, 1045\u20131060. https:\/\/doi.org\/10.3390\/cells1041045 (2012).","journal-title":"Cells"},{"key":"41026_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3727\/096368916x690881","volume":"25","author":"M Dezawa","year":"2016","unstructured":"Dezawa, M. Muse cells provide the pluripotency of mesenchymal stem cells: direct contribution of muse cells to tissue regeneration. Cell Transpl. 25, 849\u2013861. https:\/\/doi.org\/10.3727\/096368916x690881 (2016).","journal-title":"Cell Transpl."},{"key":"41026_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/circresaha.117.311648","volume":"122","author":"Y Yamada","year":"2018","unstructured":"Yamada, Y. et al. S1P\u2013S1PR2 axis mediates homing of muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction. Circ. Res. 122, 1069\u20131083. https:\/\/doi.org\/10.1161\/circresaha.117.311648 (2018).","journal-title":"Circ. Res."},{"key":"41026_CR20","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1681\/asn.2016070775","volume":"28","author":"N Uchida","year":"2017","unstructured":"Uchida, N. et al. Beneficial effects of systemically administered human muse cells in adriamycin nephropathy. J. Am. Soc. Nephrol. 28, 2946\u20132960. https:\/\/doi.org\/10.1681\/asn.2016070775 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"41026_CR21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3727\/096368916x693662","volume":"26","author":"M Iseki","year":"2017","unstructured":"Iseki, M. et al. Muse cells, nontumorigenic pluripotent-like stem cells, have liver regeneration capacity through specific homing and cell replacement in a mouse model of liver fibrosis. Cell Transpl. 26, 821\u2013840. https:\/\/doi.org\/10.3727\/096368916x693662 (2017).","journal-title":"Cell Transpl."},{"key":"41026_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5966\/sctm.2014-0181","volume":"4","author":"K Kinoshita","year":"2015","unstructured":"Kinoshita, K. et al. Therapeutic potential of adipose-derived SSEA-3-positive muse cells for treating diabetic skin ulcers. Stem Cells Transl. Med. 4, 146\u2013155. https:\/\/doi.org\/10.5966\/sctm.2014-0181 (2015).","journal-title":"Stem Cells Transl. Med."},{"key":"41026_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/cells10040961","volume":"10","author":"T Yamashita","year":"2021","unstructured":"Yamashita, T., Kushida, Y., Abe, K. & Dezawa, M. Non-tumorigenic pluripotent reparative muse cells provide a new therapeutic approach for neurologic diseases. Cells 10, 961 (2021).","journal-title":"Cells"},{"key":"41026_CR24","doi-asserted-by":"publisher","unstructured":"Ozuru, R. et al. Rescue from Stx2-producing E.\u00a0coli-associated encephalopathy by intravenous injection of muse cells in NOD-SCID mice. Mol. Ther. 28, 100\u2013118. https:\/\/doi.org\/10.1016\/j.ymthe.2019.09.023 (2020).","DOI":"10.1016\/j.ymthe.2019.09.023"},{"key":"41026_CR25","doi-asserted-by":"publisher","first-page":"17102","DOI":"10.1038\/s41598-020-74216-4","volume":"10","author":"T Yamashita","year":"2020","unstructured":"Yamashita, T. et al. Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis. Sci. Rep. 10, 17102. https:\/\/doi.org\/10.1038\/s41598-020-74216-4 (2020).","journal-title":"Sci. Rep."},{"key":"41026_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1161\/strokeaha.116.014950","volume":"48","author":"H Uchida","year":"2017","unstructured":"Uchida, H. et al. Human muse cells reconstruct neuronal circuitry in subacute lacunar stroke model. Stroke 48, 428\u2013435. https:\/\/doi.org\/10.1161\/strokeaha.116.014950 (2017).","journal-title":"Stroke"},{"key":"41026_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/stem.2206","volume":"34","author":"H Uchida","year":"2016","unstructured":"Uchida, H. et al. Transplantation of unique subpopulation of fibroblasts, muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation. Stem Cells 34, 160\u2013173. https:\/\/doi.org\/10.1002\/stem.2206 (2016).","journal-title":"Stem Cells"},{"key":"41026_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/strokeaha.119.026589","volume":"51","author":"T Abe","year":"2020","unstructured":"Abe, T. et al. Intravenously transplanted human multilineage-differentiating stress-enduring cells afford brain repair in a mouse lacunar stroke model. Stroke 51, 601\u2013611. https:\/\/doi.org\/10.1161\/strokeaha.119.026589 (2020).","journal-title":"Stroke"},{"key":"41026_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1096\/fj.04-2078rev","volume":"19","author":"JS Hunt","year":"2005","unstructured":"Hunt, J. S., Petroff, M. G., McIntire, R. H. & Ober, C. HLA-G and immune tolerance in pregnancy. FASEB J. 19, 681\u2013693. https:\/\/doi.org\/10.1096\/fj.04-2078rev (2005).","journal-title":"FASEB J."},{"key":"41026_CR30","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1253\/circj.CJ-20-0307","volume":"84","author":"T Noda","year":"2020","unstructured":"Noda, T., Nishigaki, K. & Minatoguchi, S. Safety and efficacy of human muse cell-based product for acute myocardial infarction in a first-in-human trial. Circ. J. 84, 1189\u20131192. https:\/\/doi.org\/10.1253\/circj.CJ-20-0307 (2020).","journal-title":"Circ. J."},{"key":"41026_CR31","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1111\/jdv.17201","volume":"35","author":"Y Fujita","year":"2021","unstructured":"Fujita, Y. et al. Intravenous allogeneic multilineage-differentiating stress-enduring cells in adults with dystrophic epidermolysis bullosa: A phase 1\/2 open-label study. J. Eur. Acad. Dermatol. Venereol. JEADV 35, e528\u2013e531. https:\/\/doi.org\/10.1111\/jdv.17201 (2021).","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"41026_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X20972656","author":"T Suzuki","year":"2020","unstructured":"Suzuki, T. et al. Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy. J. Cereb. Blood Flow Metab. https:\/\/doi.org\/10.1177\/0271678X20972656 (2020).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"41026_CR33","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1089\/cbr.2011.1146","volume":"27","author":"A Mukherjee","year":"2012","unstructured":"Mukherjee, A. et al. Radiolabeling of umbilical cord-derived mesenchymal stem cells for in vivo tracking. Cancer Biother. Radiopharm. 27, 614\u2013619. https:\/\/doi.org\/10.1089\/cbr.2011.1146 (2012).","journal-title":"Cancer Biother. Radiopharm."},{"key":"41026_CR34","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1172\/jci102855","volume":"32","author":"FG Ebaugh Jr","year":"1953","unstructured":"Ebaugh, F. G. Jr., Emerson, C. P. & Ross, J. F. The use of radioactive chromium 51 as an erythrocyte tagging agent for the determination or red cell survival in vivo. J. Clin. Investig. 32, 1260\u20131276. https:\/\/doi.org\/10.1172\/jci102855 (1953).","journal-title":"J. Clin. Investig."},{"key":"41026_CR35","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1172\/jci102404","volume":"29","author":"K Sterling","year":"1950","unstructured":"Sterling, K. & Gray, S. J. Determination of the circulating red cell volume in man by radioactive chromium. J. Clin. Investig. 29, 1614\u20131619. https:\/\/doi.org\/10.1172\/jci102404 (1950).","journal-title":"J. Clin. Investig."},{"key":"41026_CR36","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.bbamem.2017.03.008","volume":"1573\u20131582","author":"I Karunakaran","year":"1859","unstructured":"Karunakaran, I. & van Echten-Deckert, G. Sphingosine 1-phosphate\u2014A double edged sword in the brain. Biochim. Biophys. Acta 1573\u20131582, 2017. https:\/\/doi.org\/10.1016\/j.bbamem.2017.03.008 (1859).","journal-title":"Biochim. Biophys. Acta"},{"key":"41026_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1203\/01.pdr.0000251612.16069.4b","volume":"61","author":"S Ashwal","year":"2007","unstructured":"Ashwal, S., Tone, B., Tian, H. R., Chong, S. & Obenaus, A. Comparison of two neonatal ischemic injury models using magnetic resonance imaging. Pediatr. Res. 61, 9\u201314. https:\/\/doi.org\/10.1203\/01.pdr.0000251612.16069.4b (2007).","journal-title":"Pediatr. Res."},{"key":"41026_CR38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/0963689718761657","volume":"27","author":"H Yabuki","year":"2018","unstructured":"Yabuki, H., Wakao, S., Kushida, Y., Dezawa, M. & Okada, Y. Human multilineage-differentiating stress-enduring cells exert pleiotropic effects to ameliorate acute lung ischemia-reperfusion injury in a rat model. Cell Transpl. 27, 979\u2013993. https:\/\/doi.org\/10.1177\/0963689718761657 (2018).","journal-title":"Cell Transpl."},{"key":"41026_CR39","doi-asserted-by":"publisher","first-page":"A8","DOI":"10.1186\/cc11266","volume":"16","author":"KH Polderman","year":"2012","unstructured":"Polderman, K. H. Is therapeutic hypothermia immunosuppressive?. Crit. Care 16, A8. https:\/\/doi.org\/10.1186\/cc11266 (2012).","journal-title":"Crit. Care"},{"key":"41026_CR40","doi-asserted-by":"publisher","unstructured":"Sato, Y. et al. Grafting of neural stem and progenitor cells to the hippocampus of young, irradiated mice causes gliosis and disrupts the granule cell layer. Cell Death Dis. 4, e591. https:\/\/doi.org\/10.1038\/cddis.2013.92 (2013).","DOI":"10.1038\/cddis.2013.92"},{"key":"41026_CR41","doi-asserted-by":"publisher","first-page":"22368","DOI":"10.3390\/ijms160922368","volume":"16","author":"BJ Dixon","year":"2015","unstructured":"Dixon, B. J., Reis, C., Ho, W. M., Tang, J. & Zhang, J. H. Neuroprotective strategies after neonatal hypoxic ischemic encephalopathy. Int. J. Mol. Sci. 16, 22368\u201322401. https:\/\/doi.org\/10.3390\/ijms160922368 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"41026_CR42","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1080\/14767058.2018.1468881","volume":"32","author":"Q Wang","year":"2019","unstructured":"Wang, Q., Lv, H., Lu, L., Ren, P. & Li, L. Neonatal hypoxic-ischemic encephalopathy: emerging therapeutic strategies based on pathophysiologic phases of the injury. J. Maternal-fetal Neonat. Med. 32, 3685\u20133692. https:\/\/doi.org\/10.1080\/14767058.2018.1468881 (2019).","journal-title":"J. Maternal-fetal Neonat. Med."},{"key":"41026_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/14737175.2017.1259567","volume":"17","author":"EP Y\u0131ld\u0131z","year":"2017","unstructured":"Y\u0131ld\u0131z, E. P., Ekici, B. & Tatl\u0131, B. Neonatal hypoxic ischemic encephalopathy: An update on disease pathogenesis and treatment. Expert Rev. Neurother. 17, 449\u2013459. https:\/\/doi.org\/10.1080\/14737175.2017.1259567 (2017).","journal-title":"Expert Rev. Neurother."},{"key":"41026_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","volume":"106\u2013107","author":"BD Semple","year":"2013","unstructured":"Semple, B. D., Blomgren, K., Gimlin, K., Ferriero, D. M. & Noble-Haeusslein, L. J. Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog. Neurobiol. 106\u2013107, 1\u201316. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.04.001 (2013).","journal-title":"Prog. Neurobiol."},{"key":"41026_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fneur.2013.00036","volume":"4","author":"R Pressler","year":"2013","unstructured":"Pressler, R. & Auvin, S. Comparison of brain maturation among species: An example in translational research suggesting the possible use of bumetanide in newborn. Front. Neurol. 4, 36. https:\/\/doi.org\/10.3389\/fneur.2013.00036 (2013).","journal-title":"Front. Neurol."},{"key":"41026_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fneur.2015.00155","volume":"6","author":"J Boltze","year":"2015","unstructured":"Boltze, J. et al. The dark side of the force\u2014Constraints and complications of cell therapies for stroke. Front. Neurol. 6, 155. https:\/\/doi.org\/10.3389\/fneur.2015.00155 (2015).","journal-title":"Front. Neurol."},{"key":"41026_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/pr.2015.100","volume":"78","author":"SD Patel","year":"2015","unstructured":"Patel, S. D. et al. Therapeutic hypothermia and hypoxia\u2013ischemia in the term-equivalent neonatal rat: Characterization of a translational preclinical model. Pediatr. Res. 78, 264\u2013271. https:\/\/doi.org\/10.1038\/pr.2015.100 (2015).","journal-title":"Pediatr. Res."},{"key":"41026_CR48","doi-asserted-by":"publisher","unstructured":"Campion, S. et al. The benefits, limitations and opportunities of preclinical models for neonatal drug development. Disease Models Mech. https:\/\/doi.org\/10.1242\/dmm.049065 (2022).","DOI":"10.1242\/dmm.049065"},{"key":"41026_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fneur.2016.00057","volume":"7","author":"P Rumajogee","year":"2016","unstructured":"Rumajogee, P., Bregman, T., Miller, S. P., Yager, J. Y. & Fehlings, M. G. Rodent hypoxia-ischemia models for cerebral palsy research: A systematic review. Front. Neurol. 7, 57. https:\/\/doi.org\/10.3389\/fneur.2016.00057 (2016).","journal-title":"Front. Neurol."},{"key":"41026_CR50","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.3390\/ijms24054351","volume":"24","author":"T Nguyen","year":"2023","unstructured":"Nguyen, T. et al. Umbilical cord blood-derived cell therapy for perinatal brain injury: A systematic review & meta-analysis of preclinical studies. Int. J. Mol. Sci. 24, 4351. https:\/\/doi.org\/10.3390\/ijms24054351 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"41026_CR51","doi-asserted-by":"publisher","unstructured":"Park, W. S. et al. Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy. PLoS ONE 10, e0120893. https:\/\/doi.org\/10.1371\/journal.pone.0120893 (2015).","DOI":"10.1371\/journal.pone.0120893"},{"key":"41026_CR52","doi-asserted-by":"publisher","first-page":"7665","DOI":"10.1038\/s41598-018-25902-x","volume":"8","author":"SY Ahn","year":"2018","unstructured":"Ahn, S. Y., Chang, Y. S., Sung, D. K., Sung, S. I. & Park, W. S. Hypothermia broadens the therapeutic time window of mesenchymal stem cell transplantation for severe neonatal hypoxic ischemic encephalopathy. Sci. Rep. 8, 7665. https:\/\/doi.org\/10.1038\/s41598-018-25902-x (2018).","journal-title":"Sci. Rep."},{"key":"41026_CR53","doi-asserted-by":"publisher","unstructured":"Matsuyama, N. et al. Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial. BMJ Open 12, e057073. https:\/\/doi.org\/10.1136\/bmjopen-2021-057073 (2022).","DOI":"10.1136\/bmjopen-2021-057073"},{"key":"41026_CR54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ana.410090206","volume":"9","author":"JE Rice 3rd","year":"1981","unstructured":"Rice, J. E. 3rd., Vannucci, R. C. & Brierley, J. B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9, 131\u2013141. https:\/\/doi.org\/10.1002\/ana.410090206 (1981).","journal-title":"Ann. Neurol."},{"key":"41026_CR55","doi-asserted-by":"publisher","DOI":"10.1159\/000455836","author":"A Mikrogeorgiou","year":"2017","unstructured":"Mikrogeorgiou, A. et al. Dedifferentiated fat cells as a novel source for cell therapy to target neonatal hypoxic-ischemic encephalopathy. Dev. Neurosci. https:\/\/doi.org\/10.1159\/000455836 (2017).","journal-title":"Dev. Neurosci."},{"key":"41026_CR56","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/s0028-3908(00)00005-8","volume":"39","author":"T Schallert","year":"2000","unstructured":"Schallert, T., Fleming, S. M., Leasure, J. L., Tillerson, J. L. & Bland, S. T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39, 777\u2013787. https:\/\/doi.org\/10.1016\/s0028-3908(00)00005-8 (2000).","journal-title":"Neuropharmacology"},{"key":"41026_CR57","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nature11356","volume":"489","author":"S Han","year":"2012","unstructured":"Han, S. et al. Autistic-like behaviour in Scn1a+\/- mice and rescue by enhanced GABA-mediated neurotransmission. Nature 489, 385\u2013390. https:\/\/doi.org\/10.1038\/nature11356 (2012).","journal-title":"Nature"},{"key":"41026_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris, R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47\u201360. https:\/\/doi.org\/10.1016\/0165-0270(84)90007-4 (1984).","journal-title":"J. Neurosci. Methods"},{"key":"41026_CR59","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1269\/jrr.45.563","volume":"45","author":"N Takai","year":"2004","unstructured":"Takai, N., Sun, X. Z., Ando, K., Mishima, K. & Takahashi, S. Ectopic neurons in the hippocampus may be a cause of learning disability after prenatal exposure to X-rays in rats. J. Radiat. Res. 45, 563\u2013569. https:\/\/doi.org\/10.1269\/jrr.45.563 (2004).","journal-title":"J. Radiat. Res."},{"key":"41026_CR60","unstructured":"Paxinous G & C, W. The rat brain in stereotaxic coordinates, ed 2. San Diego Academic Press (1986)."},{"key":"41026_CR61","doi-asserted-by":"publisher","first-page":"7994","DOI":"10.1523\/jneurosci.20-21-07994.2000","volume":"20","author":"W Nakajima","year":"2000","unstructured":"Nakajima, W. et al. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J. Neurosci. 20, 7994\u20138004. https:\/\/doi.org\/10.1523\/jneurosci.20-21-07994.2000 (2000).","journal-title":"J. Neurosci."},{"key":"41026_CR62","doi-asserted-by":"publisher","first-page":"87s","DOI":"10.1177\/0192623312439125","volume":"40","author":"W Kaufmann","year":"2012","unstructured":"Kaufmann, W. et al. Proliferative and nonproliferative lesions of the rat and mouse central and peripheral nervous systems. Toxicol. Pathol. 40, 87s\u2013157s. https:\/\/doi.org\/10.1177\/0192623312439125 (2012).","journal-title":"Toxicol. Pathol."},{"key":"41026_CR63","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.freeradbiomed.2015.12.015","volume":"91","author":"K Imai","year":"2016","unstructured":"Imai, K. et al. Neuroprotective potential of molecular hydrogen against perinatal brain injury via suppression of activated microglia. Free Radical Biol. Med. 91, 154\u2013163. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.12.015 (2016).","journal-title":"Free Radical Biol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41026-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41026-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41026-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T14:14:46Z","timestamp":1700316886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41026-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41026"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-41026-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,11]]},"assertion":[{"value":"19 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"YS, SS, TS, MM, MH and MD declare the following potential conflicts of interest with respect to the research, authorship, and\/or publication of this article: YS and SS have a collaborative research agreement for perinatal disease and an investigator-initiated clinical trial agreement supplying CL2020 free of charge for HIE with Life Science Institute Inc. (LSII). SS has a contract for consulting with LSII. YS, SS, TS, MM, MH, and MD have a patent for the application of Muse cells for the treatment of perinatal brain damage and other indications. MD is party to a collaborative research agreement with LSII. MD has a patent for the application of Muse cells for the treatment of cerebral infarction. MD holds patents for Muse cells and the isolation method thereof, which are exclusively licensed to LSII. KU, AO, RM, SG, HM, YK, YY, KI, MT, KM and YT declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14958"}}